---
title: "Keymed Biosciences, Inc. (2162) Gets a Buy from Huatai Securities"
description: "Huatai Securities has maintained a Buy rating on Keymed Biosciences, Inc. (2162) with a price target of HK$91.08. Additionally, Goldman Sachs also issued a Buy rating on the company. However, TR | Ope"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/264562252.md"
published_at: "2025-11-06T05:07:46.000Z"
---

# Keymed Biosciences, Inc. (2162) Gets a Buy from Huatai Securities

> Huatai Securities has maintained a Buy rating on Keymed Biosciences, Inc. (2162) with a price target of HK$91.08. Additionally, Goldman Sachs also issued a Buy rating on the company. However, TR | OpenAI reiterated a Hold rating on October 23.

In a report released yesterday, from Huatai Securities maintained a Buy rating on Keymed Biosciences, Inc., with a price target of HK$91.08.

### Meet Your ETF AI Analyst

-   Discover how TipRanks' *ETF* AI Analyst can help you make smarter investment decisions
-   Explore ETFs TipRanks' users love and see what insights the ***ETF* AI Analyst** reveals about the ones you follow.

In addition to Huatai Securities, Keymed Biosciences, Inc. also received a Buy from Goldman Sachs’s Ziyi Chen in a report issued on November 2. However, on October 23, TR | OpenAI – 4o reiterated a Hold rating on Keymed Biosciences, Inc. (HKEX: 2162).

### Related Stocks

- [02162.HK - KEYMED BIO-B](https://longbridge.com/en/quote/02162.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| OpenAI’s latest paper exposes the risks of AI in smart contracts | OpenAI's latest paper highlights the risks of AI in smart contracts, particularly as they manage over $400 billion in as | [Link](https://longbridge.com/en/news/276373111.md) |
| Add Foreign Exposure to Your Portfolio with This 1 ETF | Add Foreign Exposure to Your Portfolio with This 1 ETF | [Link](https://longbridge.com/en/news/276628913.md) |
| CORRECTION FROM SOURCE: Evolve Plans to Launch the Evolve All-in-One UltraYield ETF | Evolve Funds Group Inc. has filed a preliminary prospectus to launch the Evolve All-in-One UltraYield ETF (EASY) on the  | [Link](https://longbridge.com/en/news/276476418.md) |
| Here Are 3 Technology ETFs with At Least 20% Upside Potential | Investors looking to benefit from growth in AI, cloud computing, and other tech sectors may consider three technology ET | [Link](https://longbridge.com/en/news/276603071.md) |
| REG - UBS ETF JPM GOV HGBP - Net Asset Value(s) | UBS ETF JPM GOV HGBP has reported its net asset value (NAV) per share as of February 19, 2026, at £11.2669. The fund, id | [Link](https://longbridge.com/en/news/276425777.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.